WHAT'S NEW THIS SUNDAY: THREE ON HEP B
· THREE ON HEP B · HIV–HBV COINFECTION HIV–HBV Coinfection — A Global Challenge Athena P. Kourtis, M.D., Ph.D., M.P.H., Marc Bulterys, M.D., Ph.D., Dale J. Hu, M.D., M.P.H., and Denise J. Jamieson, M.D., ... read more--- Horizontal Transmission of Hepatitis B Virus ...
· HORIZONTAL TRANSMISSION OF HEPATITIS B VIRUS—WHY DISCUSS WHEN WE CAN VACCINATE? ‘[A] global policy of universal HBV vaccination is ultimately the only way to eliminate HBV transmission and prevent serious HBV-related liver d ... read more--- Vaccination of Health Care Workers
VACCINATION OF HEALTH CARE WORKERS ‘Vaccination of health care workers to protect patients at increased risk for acute respiratory disease,’ Emerging Infectious Diseases, Volume 18, Number 8— August 2012 Gayl ... read more--- Vaccines versus Viruses
VACCINES VS VIRUSES New York Times, 23 July 2012 Q. Why didn’t viruses like polio and other diseases mutate to become immune to vaccines? A. “Bacteria mutate very well, but vaccines don't give viruses much of a chance,&rdq ... read more--- Reduced Price on Rotavirus Vaccines
REDUCED PRICE ON ROTAVIRUS VACCINES From conclusion; full text is at http://www.who.int/bulletin/volumes/90/7/11-094656/en/index.html The two major pharmaceutical companies that manufacture rotavirus vaccines have recently offered to sel ... read more--- Two on Factors Affecting Vaccination Coverage ...
TWO ON FACTORS AFFECTING VACCINATION COVERAGE IN SUB-SAHARAN AFRICA AND IN INDIA ‘Contrary to expectation, we found children from urban areas were more likely to be unimmunised than those from rural areas . . . ‘The few currently a ... read moreWHAT'S NEW THIS THURSDAY: ECONOMIC IMPACT OF VACCI ...
· ECONOMIC IMPACT OF VACCINATION Systematic review of studies evaluating the broader economic impact of vaccination in low and middle income countries Rohan Deogaonkar, Raymond Hutubessy, Inge Putten, Silv ... read more---Removing the Age Restrictions for Rotavirus Vac ...
REMOVING THE AGE RESTRICTIONS FOR ROTAVIRUS VACCINATION: A BENEFIT-RISK MODELING ANALYSIS Manish M. Patel1*, Andrew D. Clark2, Colin F. B. Sanderson2, Jacqueline Tate1, Umesh D. Parashar1 Editors' Summary below; full text, with tables ... read moreAre three drugs for malaria better than two?
Friday, 24th of April 2020 |
Public health Interventions and epidemic intensity during the 1918 influenza pandemic
Thursday, 16th of April 2020 |
Chloroquine and hydroxychloroquine as available weapons to fight COVID-19
Tuesday, 17th of March 2020 |
Using models to shape measles control and elimination strategies in low- and middle-income countries: A review of recent applications
Monday, 17th of February 2020 |
Immunization Agenda 2030
Tuesday, 11th of February 2020 |
41245618 |
www.measlesinitiative.org www.technet21.org www.polioeradication.org www.globalhealthlearning.org www.who.int/bulletin allianceformalariaprevention.com www.malariaworld.org http://www.panafrican-med-journal.com/ |